Beijing Scitop Bio-tech Co., Ltd.

Shenzhen Stock Exchange 300858.SZ

Beijing Scitop Bio-tech Co., Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 244.09 M

Beijing Scitop Bio-tech Co., Ltd. Shareholders' Equity is USD 244.09 M for the year ending December 31, 2023, a -0.71% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Beijing Scitop Bio-tech Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 245.85 M, a 61.48% change year over year.
  • Beijing Scitop Bio-tech Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 152.25 M, a 6.56% change year over year.
  • Beijing Scitop Bio-tech Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 142.87 M, a 148.84% change year over year.
  • Beijing Scitop Bio-tech Co., Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 57.42 M, a 30.83% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
SV Wall Street
Shenzhen Stock Exchange: 300858.SZ

Beijing Scitop Bio-tech Co., Ltd.

CEO Mr. Xiaojun Liu
IPO Date July 27, 2020
Location China
Headquarters No.1-2, Yard 31
Employees 330
Sector Consumers Staples
Industries
Dairy & Milk Baby & Childcare Cosmetics Frozen Foods Organic Foods Personal Care Pet Food Plastics
Description

Beijing Scitop Bio-tech Co., Ltd. develops, produces, and sells probiotic lactic acid bacteria and related products in China. It also provides compound food additives, edible probiotic products, and animal and plant microecological preparations. Its products have applications in the food industry, health care, animal husbandry, and agricultural planting. Beijing Scitop Bio-tech Co., Ltd. was founded in 2003 and is headquartered in Beijing, China.

StockViz Staff

February 2, 2025

Any question? Send us an email